Sianou Argiri, Galyfos George, Moragianni Dimitra, Andromidas Panagiotis, Kaparos Georgios, Baka Stavroula, Kouskouni Evangelia
Department of Microbiology, Areteion Hospital, University of Athens Medical School, Athens, Greece,
Arch Gynecol Obstet. 2015 Aug;292(2):271-82. doi: 10.1007/s00404-015-3660-y. Epub 2015 Feb 20.
Epigenetics seem to play a primary role in the current research on the pathogenesis of different types of endometrial cancer. Data so far indicate that microRNAs regulate different pathways that could lead to carcinogenesis when not functioning properly. The aim of this review is to summarize current knowledge on microRNAs that have been associated with endometrial cancer development.
From July 2014 to August 2014, we conducted a comprehensive research utilizing major online search engines (Pubmed, Crossref, Google Scholar). The main keywords used in our search were endometrial cancer/carcinoma; microRNA; epigenetics; novel biomarkers; pathogenesis.
Overall, we identified 155 studies, although only 77 were eligible for this review. Different miRNAs were identified to contribute either promoting the carcinogenesis in the endometrium or inhibiting different steps of endometrial cancer development. Tumour growth, cell proliferation, apoptosis and invasion metastasis have been identified as the main processes where miRNAs seem to be implicated.
microRNAs are effective regulators of gene expression that has a significant role in the pathogenesis of endometrial cancer. Research concerning possible therapeutic implications has been promising, although there is still a significant distance to be covered between research observations and clinical results. Extensive preclinical and translational research is still required to improve the efficacy and minimize unwanted effects of miRNAs-based therapy.
表观遗传学似乎在当前不同类型子宫内膜癌发病机制的研究中发挥着主要作用。目前的数据表明,微小RNA调控着不同的信号通路,当这些通路功能异常时可能导致癌症发生。本综述的目的是总结目前关于与子宫内膜癌发生相关的微小RNA的知识。
2014年7月至2014年8月,我们利用主要的在线搜索引擎(PubMed、Crossref、谷歌学术)进行了全面的研究。我们搜索中使用的主要关键词是子宫内膜癌/腺癌;微小RNA;表观遗传学;新型生物标志物;发病机制。
总体而言,我们共识别出155项研究,尽管只有77项符合本综述的要求。已确定不同的微小RNA要么促进子宫内膜的癌变,要么抑制子宫内膜癌发展的不同阶段。肿瘤生长、细胞增殖、凋亡和侵袭转移已被确定为微小RNA似乎涉及的主要过程。
微小RNA是基因表达的有效调节因子,在子宫内膜癌的发病机制中起着重要作用。关于其可能的治疗意义的研究前景良好,尽管研究观察结果与临床结果之间仍有很大差距。仍需要广泛的临床前和转化研究来提高基于微小RNA治疗的疗效并将不良反应降至最低。